IPILIMUMAB

IPILIMUMAB was reported 43846 times

IPILIMUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPOPHYSITIS 1086 0.5395
1 LYMPHOCYTIC HYPOPHYSITIS 143 0.5181
2 IMMUNE-MEDIATED HYPOPITUITARISM 15 0.4545
3 IMMUNE-MEDIATED UVEITIS 82 0.4481
4 AUTOIMMUNE COLITIS 284 0.4403
5 IMMUNE-MEDIATED HYPOPHYSITIS 186 0.4124
6 IMMUNE-MEDIATED GASTROINTESTINAL DISORDER 17 0.3953
7 IMMUNE-MEDIATED ENDOCRINOPATHY 51 0.3400
8 ENDOCRINE TOXICITY 33 0.3235
9 IMMUNE-MEDIATED ENTEROCOLITIS 1171 0.3181
10 IMMUNE-MEDIATED DERMATITIS 304 0.3016
11 IMMUNE-MEDIATED THYROIDITIS 131 0.2652
12 IMMUNE-MEDIATED HEPATITIS 540 0.2642
13 IMMUNE-MEDIATED HYPERTHYROIDISM 67 0.2638
14 HYPOPITUITARISM 433 0.2487
15 IMMUNE-MEDIATED CYSTITIS 28 0.2435
16 LEUKODERMA 45 0.2261
17 AUTOIMMUNE DERMATITIS 34 0.2252
18 ADRENALITIS 24 0.2243
19 IMMUNE-MEDIATED NEPHRITIS 104 0.2217
20 AUTOIMMUNE NEPHRITIS 47 0.2136
21 IMMUNE-MEDIATED HEPATIC DISORDER 417 0.2136
22 IMMUNE-MEDIATED LUNG DISEASE 385 0.2110
23 FULMINANT TYPE 1 DIABETES MELLITUS 217 0.2105
24 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 184 0.2096
25 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 167 0.2095
26 IMMUNE-MEDIATED ENCEPHALOPATHY 18 0.2022
27 IMMUNE-MEDIATED ARTHRITIS 75 0.1969
28 IMMUNE-MEDIATED ENCEPHALITIS 104 0.1966
29 IMMUNE-MEDIATED NEUROLOGICAL DISORDER 17 0.1954
30 INTESTINAL INTRAEPITHELIAL LYMPHOCYTES INCREASED 13 0.1940
31 IMMUNE-MEDIATED CHOLANGITIS 67 0.1866
32 IMMUNE-MEDIATED HYPOTHYROIDISM 210 0.1862
33 PITUITARY ENLARGEMENT 37 0.1814
34 IMMUNE-MEDIATED PANCREATITIS 69 0.1811
35 AUTOIMMUNE ARTHRITIS 28 0.1783
36 IMMUNE-MEDIATED MYOCARDITIS 288 0.1782
37 BRAIN RADIATION NECROSIS 13 0.1757
38 IMMUNE-MEDIATED MYASTHENIA GRAVIS 57 0.1754
39 IMMUNE-MEDIATED GASTRITIS 33 0.1719
40 IMMUNE-MEDIATED OESOPHAGITIS 12 0.1667
41 VOGT-KOYANAGI-HARADA DISEASE 35 0.1591
42 SECONDARY ADRENOCORTICAL INSUFFICIENCY 231 0.1529
43 SILENT THYROIDITIS 22 0.1528
44 MENINGORADICULITIS 16 0.1481
45 IMMUNE-MEDIATED PNEUMONITIS 33 0.1410
46 MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME 32 0.1404
47 IMMUNE-MEDIATED RENAL DISORDER 57 0.1377
48 NEUROFIBROSARCOMA 14 0.1359
49 AUTOIMMUNE LUNG DISEASE 15 0.1271
50 AUTOIMMUNE NEUROPATHY 16 0.1240
51 PANCREATIC TOXICITY 15 0.1240
52 HYPOTHALAMO-PITUITARY DISORDER 172 0.1181
53 THYROIDITIS 347 0.1154
54 SECONDARY HYPOTHYROIDISM 17 0.1111
55 BLOOD CORTICOTROPHIN DECREASED 54 0.1107
56 AUTOIMMUNE MYOCARDITIS 24 0.1096
57 IMMUNE-MEDIATED NEUROPATHY 16 0.1032
58 GLUCOCORTICOID DEFICIENCY 40 0.0946
59 CRYPTITIS 13 0.0935
60 AUTOIMMUNE HYPOTHYROIDISM 22 0.0924
61 ORBITAL MYOSITIS 14 0.0921
62 CENTRAL HYPOTHYROIDISM 30 0.0906
63 AUTOIMMUNE PANCREATITIS 42 0.0830
64 INTRACRANIAL TUMOUR HAEMORRHAGE 32 0.0827
65 VITILIGO 185 0.0788
66 IMMUNE-MEDIATED ADVERSE REACTION 121 0.0788
67 ADRENAL INSUFFICIENCY 955 0.0786
68 TUMOUR PSEUDOPROGRESSION 84 0.0767
69 ENDOCRINE DISORDER 96 0.0748
70 TRI-IODOTHYRONINE FREE DECREASED 19 0.0745
71 MALIGNANT NEOPLASM OLIGOPROGRESSION 14 0.0704
72 ENTEROCOLITIS 399 0.0690
73 NON-SMALL CELL LUNG CANCER 326 0.0680
74 METASTATIC MALIGNANT MELANOMA 153 0.0665
75 RADIATION NECROSIS 38 0.0663
76 PRIMARY HYPOTHYROIDISM 14 0.0660
77 CORTISOL DECREASED 73 0.0639
78 COLITIS 2337 0.0616
79 TYPE 1 DIABETES MELLITUS 368 0.0610
80 PRIMARY ADRENAL INSUFFICIENCY 18 0.0590
81 SEROUS RETINAL DETACHMENT 49 0.0585
82 AUTOIMMUNE HEPATITIS 395 0.0567
83 ADRENOCORTICAL INSUFFICIENCY ACUTE 110 0.0563
84 MYASTHENIC SYNDROME 41 0.0530
85 TUMOUR HYPERPROGRESSION 13 0.0524
86 ADRENAL DISORDER 98 0.0510
87 SARCOID-LIKE REACTION 13 0.0504
88 THROMBOPHLEBITIS MIGRANS 17 0.0500
89 MELANOMA RECURRENT 21 0.0499
90 APOPTOSIS 15 0.0485
91 SECONDARY HYPOGONADISM 16 0.0485
92 IMMUNE-MEDIATED MYOSITIS 131 0.0475
93 NEPHRITIS 154 0.0461
94 MYOCARDITIS 520 0.0453
95 CYTOMEGALOVIRUS ENTEROCOLITIS 34 0.0442
96 ENCEPHALITIS AUTOIMMUNE 56 0.0426
97 TUMOUR ASSOCIATED FEVER 17 0.0416
98 BLOOD CORTICOTROPHIN INCREASED 12 0.0415
99 HYPERTHYROIDISM 599 0.0413
100 THYROXINE FREE DECREASED 22 0.0389
101 TUMOUR PAIN 50 0.0379
102 MYOSITIS 339 0.0377
103 MALIGNANT NEOPLASM PROGRESSION 3853 0.0376
104 PNEUMONITIS 971 0.0356
105 THYROTOXIC CRISIS 40 0.0351
106 PARVOVIRUS INFECTION 14 0.0347
107 EOSINOPHILIC FASCIITIS 12 0.0346
108 RADIATION PNEUMONITIS 74 0.0345
109 DIABETIC KETOSIS 13 0.0342
110 AMYLASE INCREASED 125 0.0338
111 ENTEROCOLITIS HAEMORRHAGIC 48 0.0324
112 EXPOSURE VIA BODY FLUID 25 0.0318
113 AUTOIMMUNE HAEMOLYTIC ANAEMIA 103 0.0300
114 MENINGITIS ASEPTIC 134 0.0298
115 AUTOIMMUNE THYROIDITIS 111 0.0293
116 ENCEPHALITIS 203 0.0293
117 LIPASE INCREASED 224 0.0292
118 CYTOKINE RELEASE SYNDROME 569 0.0283
119 DEMYELINATING POLYNEUROPATHY 29 0.0282
120 MYASTHENIA GRAVIS 224 0.0277
121 IRIS ADHESIONS 14 0.0273
122 PERIPHERAL MOTOR NEUROPATHY 38 0.0271
123 GUILLAIN-BARRE SYNDROME 131 0.0271
124 HYPOTHYROIDISM 852 0.0267
125 CYTOKINE STORM 18 0.0263
126 HEPATITIS 660 0.0258
127 AUTOIMMUNE DISORDER 249 0.0255
128 LICHENOID KERATOSIS 58 0.0254
129 GIANT CELL ARTERITIS 21 0.0253
130 PRERENAL FAILURE 35 0.0248
131 METASTASES TO CENTRAL NERVOUS SYSTEM 320 0.0248
132 DUODENITIS 76 0.0247
133 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 182 0.0242
134 METASTASES TO SKIN 25 0.0242
135 HEPATOBILIARY DISEASE 15 0.0240
136 PRESCRIBED OVERDOSE 462 0.0239
137 LARGE INTESTINE PERFORATION 165 0.0237
138 TUMOUR HAEMORRHAGE 67 0.0235
139 BLOOD CORTISOL DECREASED 15 0.0234
140 CHORIORETINITIS 15 0.0233
141 METASTASES TO ADRENALS 21 0.0228
142 PULMONARY SEPSIS 33 0.0227
143 EROSIVE DUODENITIS 18 0.0225
144 ENTERITIS 140 0.0219
145 CHOLANGITIS SCLEROSING 44 0.0214
146 PULMONARY SARCOIDOSIS 24 0.0214
147 SIALOADENITIS 29 0.0213
148 IRIDOCYCLITIS 67 0.0212
149 THYROXINE DECREASED 13 0.0210
150 BLOOD THYROID STIMULATING HORMONE DECREASED 94 0.0207
151 GLOMERULONEPHRITIS MINIMAL LESION 15 0.0207
152 PEMPHIGOID 154 0.0204
153 GASTROINTESTINAL TOXICITY 96 0.0200
154 HYPOGONADISM 20 0.0198
155 ENTEROCOLITIS INFECTIOUS 18 0.0195
156 CHRONIC GASTRITIS 44 0.0195
157 MYELITIS 30 0.0194
158 CAPILLARY LEAK SYNDROME 40 0.0193
159 INTESTINAL PERFORATION 217 0.0193
160 TUMOUR NECROSIS 20 0.0189
161 SKIN TOXICITY 107 0.0189
162 PULMONARY TOXICITY 133 0.0188
163 OVERLAP SYNDROME 13 0.0186
164 TEMPORAL ARTERITIS 17 0.0184
165 POLYMYALGIA RHEUMATICA 58 0.0182
166 LYMPHANGIOSIS CARCINOMATOSA 19 0.0182
167 UVEITIS 243 0.0179
168 PANCREATIC ENZYMES INCREASED 26 0.0177
169 METASTASES TO MENINGES 40 0.0176
170 CHOLANGITIS 109 0.0176
171 CRANIAL NERVE DISORDER 12 0.0172
172 DIABETIC KETOACIDOSIS 408 0.0170
173 IMMUNE THROMBOCYTOPENIA 77 0.0168
174 BILE DUCT STENOSIS 20 0.0167
175 THYROID DISORDER 253 0.0164
176 POLYMYOSITIS 29 0.0164
177 MYELITIS TRANSVERSE 23 0.0163
178 VITH NERVE PARALYSIS 18 0.0158
179 HYPOPARATHYROIDISM 12 0.0156
180 INTENTIONAL PRODUCT USE ISSUE 1345 0.0153
181 STEROID DIABETES 23 0.0153
182 RHEUMATIC DISORDER 29 0.0150
183 HYPERSENSITIVITY PNEUMONITIS 17 0.0149
184 FACIAL PARALYSIS 127 0.0149
185 CANCER PAIN 38 0.0148
186 MALIGNANT PLEURAL EFFUSION 25 0.0148
187 NON-SMALL CELL LUNG CANCER METASTATIC 13 0.0148
188 RASH MACULO-PAPULAR 329 0.0148
189 PANCREATIC FAILURE 26 0.0147
190 LYMPHADENOPATHY MEDIASTINAL 28 0.0146
191 GASTROINTESTINAL PERFORATION 60 0.0144
192 TROPONIN I INCREASED 24 0.0144
193 PREGNANCY ON CONTRACEPTIVE 21 0.0144
194 ERYTHEMA MULTIFORME 133 0.0142
195 HEPATIC FUNCTION ABNORMAL 520 0.0139
196 RADIATION SKIN INJURY 16 0.0138
197 LIVER DISORDER 606 0.0137
198 CYTOMEGALOVIRUS COLITIS 31 0.0135
199 IMMUNE THROMBOCYTOPENIC PURPURA 38 0.0134
200 DERMATOMYOSITIS 34 0.0134
201 HYPERCALCAEMIA 165 0.0133
202 MENINGITIS 87 0.0130
203 HYPERTRANSAMINASAEMIA 89 0.0128
204 INTUSSUSCEPTION 12 0.0126
205 INFECTIOUS PLEURAL EFFUSION 19 0.0125
206 SARCOIDOSIS 59 0.0124
207 THYROID FUNCTION TEST ABNORMAL 51 0.0123
208 HEPATOTOXICITY 273 0.0122
209 MEGACOLON 19 0.0121
210 LICHEN PLANUS 28 0.0121
211 POLYARTHRITIS 63 0.0119
212 TUBULOINTERSTITIAL NEPHRITIS 221 0.0118
213 RADICULOPATHY 31 0.0118
214 APLASIA PURE RED CELL 40 0.0116
215 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 13 0.0116
216 HEPATITIS FULMINANT 34 0.0114
217 DISSEMINATED INTRAVASCULAR COAGULATION 161 0.0114
218 METASTASES TO LUNG 130 0.0112
219 CARDIAC TAMPONADE 53 0.0111
220 PERIPHERAL SENSORIMOTOR NEUROPATHY 14 0.0111
221 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 16 0.0111
222 PERIPHERAL SENSORY NEUROPATHY 65 0.0111
223 TROPONIN T INCREASED 14 0.0110
224 INTERSTITIAL LUNG DISEASE 523 0.0108
225 DIABETES INSIPIDUS 26 0.0108
226 CELL DEATH 21 0.0106
227 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 40 0.0105
228 HEPATIC CYTOLYSIS 132 0.0103
229 ADVERSE EVENT 951 0.0103
230 HYPOALBUMINAEMIA 79 0.0102
231 PHYSICAL DECONDITIONING 26 0.0101
232 DIABETIC METABOLIC DECOMPENSATION 14 0.0101
233 TUMOUR LYSIS SYNDROME 88 0.0100
234 LUNG OPACITY 26 0.0099
235 DERMATITIS 206 0.0098
236 GRANULOMA 34 0.0098
237 NON-CARDIAC CHEST PAIN 31 0.0098
238 LARGE INTESTINE INFECTION 12 0.0098
239 HYPONATRAEMIA 546 0.0097
240 CYTOMEGALOVIRUS TEST POSITIVE 17 0.0095
241 ENTERITIS INFECTIOUS 16 0.0094
242 GASTRITIS HAEMORRHAGIC 14 0.0094
243 DRUG ERUPTION 166 0.0094
244 TOXIC EPIDERMAL NECROLYSIS 142 0.0093
245 TROPONIN INCREASED 71 0.0093
246 ORGANISING PNEUMONIA 46 0.0093
247 BRAIN OEDEMA 117 0.0093
248 METASTASES TO LYMPH NODES 62 0.0092
249 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 21 0.0090
250 SMALL INTESTINAL HAEMORRHAGE 18 0.0089
251 ADENOCARCINOMA 20 0.0089
252 ASPARTATE AMINOTRANSFERASE INCREASED 472 0.0089
253 COLITIS MICROSCOPIC 42 0.0089
254 DEAFNESS BILATERAL 15 0.0088
255 POLYNEUROPATHY 105 0.0088
256 NEPHROTIC SYNDROME 60 0.0087
257 EMBOLISM 72 0.0087
258 ATRIOVENTRICULAR BLOCK COMPLETE 58 0.0087
259 PNEUMONIA BACTERIAL 79 0.0086
260 ALVEOLITIS 12 0.0085
261 NEURITIS 13 0.0084
262 HAEMOLYTIC ANAEMIA 74 0.0083
263 OPHTHALMOPLEGIA 13 0.0082
264 PRODUCT PREPARATION ISSUE 54 0.0082
265 PROCTITIS 23 0.0082
266 MALIGNANT MELANOMA 110 0.0082
267 METASTATIC RENAL CELL CARCINOMA 15 0.0082
268 PERFORMANCE STATUS DECREASED 38 0.0081
269 HYPERGLYCAEMIA 295 0.0081
270 EMPYEMA 16 0.0080
271 TRANSAMINASES INCREASED 178 0.0080
272 PRESCRIBED UNDERDOSE 158 0.0079
273 BILE DUCT OBSTRUCTION 15 0.0079
274 HYPOPHOSPHATAEMIA 58 0.0078
275 IGA NEPHROPATHY 13 0.0078
276 CACHEXIA 40 0.0078
277 BLOOD THYROID STIMULATING HORMONE INCREASED 71 0.0077
278 PNEUMOCYSTIS JIROVECII PNEUMONIA 77 0.0077
279 LYMPHOCYTE COUNT INCREASED 25 0.0077
280 ALANINE AMINOTRANSFERASE INCREASED 466 0.0076
281 RASH MORBILLIFORM 21 0.0076
282 PAPILLOEDEMA 34 0.0075
283 APLASTIC ANAEMIA 39 0.0075
284 SMALL INTESTINAL PERFORATION 14 0.0075
285 METASTASES TO SPINE 25 0.0074
286 METASTASIS 53 0.0074
287 HISTIOCYTOSIS HAEMATOPHAGIC 22 0.0074
288 CHOLESTASIS 142 0.0074
289 CHOLECYSTITIS 88 0.0074
290 HEPATITIS ACUTE 48 0.0074
291 SKIN HYPOPIGMENTATION 13 0.0073
292 PLEURAL EFFUSION 445 0.0073
293 PARAPARESIS 13 0.0073
294 ESCHERICHIA URINARY TRACT INFECTION 31 0.0073
295 MULTIPLE ORGAN DYSFUNCTION SYNDROME 205 0.0072
296 HEPATOCELLULAR INJURY 102 0.0072
297 SUDDEN DEATH 76 0.0072
298 PERICARDIAL EFFUSION 166 0.0072
299 OPTIC NEURITIS 65 0.0071
300 FAILURE TO THRIVE 37 0.0071
301 CUTANEOUS VASCULITIS 26 0.0071
302 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 73 0.0071
303 SOFT TISSUE INFECTION 13 0.0071
304 OESOPHAGITIS 77 0.0070
305 DRUG-INDUCED LIVER INJURY 220 0.0070
306 HEPATIC FAILURE 211 0.0070
307 LUNG INFECTION 108 0.0069
308 GLOMERULONEPHRITIS 17 0.0069
309 ILEUS PARALYTIC 31 0.0069
310 SKIN DISORDER 231 0.0069
311 STEVENS-JOHNSON SYNDROME 152 0.0068
312 GASTROINTESTINAL OEDEMA 12 0.0068
313 METASTASES TO LIVER 118 0.0067
314 MYOPATHY 57 0.0066
315 GASTROINTESTINAL NECROSIS 19 0.0065
316 HEPATIC LESION 28 0.0065
317 RETINOPATHY 24 0.0064
318 SPINAL CORD COMPRESSION 25 0.0064
319 CYSTOID MACULAR OEDEMA 12 0.0064
320 GASTRITIS 167 0.0063
321 METASTASES TO PERITONEUM 16 0.0063
322 HYPOPROTEINAEMIA 12 0.0063
323 URINARY TRACT OBSTRUCTION 15 0.0063
324 ENCEPHALOPATHY 155 0.0063
325 OESOPHAGEAL CANDIDIASIS 25 0.0063
326 PSEUDOMEMBRANOUS COLITIS 14 0.0063
327 ERYTHEMA NODOSUM 22 0.0063
328 HYPOKALAEMIA 288 0.0062
329 ESCHERICHIA SEPSIS 18 0.0062
330 LYMPHADENITIS 15 0.0062
331 PORTAL VEIN THROMBOSIS 20 0.0062
332 HEPATITIS CHOLESTATIC 37 0.0061
333 ILEUS 76 0.0061
334 PATHOLOGICAL FRACTURE 31 0.0061
335 ATELECTASIS 59 0.0061
336 DIARRHOEA HAEMORRHAGIC 57 0.0061
337 BLOOD BILIRUBIN INCREASED 164 0.0061
338 PYREXIA 2100 0.0061
339 CLOSTRIDIUM DIFFICILE COLITIS 64 0.0060
340 EYELID PTOSIS 61 0.0060
341 BLOOD LACTATE DEHYDROGENASE INCREASED 95 0.0060
342 DEVICE RELATED SEPSIS 12 0.0060
343 DERMATITIS ACNEIFORM 36 0.0059
344 CLOSTRIDIUM TEST POSITIVE 13 0.0059
345 VENOUS THROMBOSIS 23 0.0059
346 TOXIC SKIN ERUPTION 59 0.0059
347 CHOLESTATIC LIVER INJURY 13 0.0058
348 VIITH NERVE PARALYSIS 20 0.0058
349 SEPSIS 646 0.0058
350 PANNICULITIS 14 0.0058
351 ACUTE KIDNEY INJURY 881 0.0058
352 LUNG ABSCESS 12 0.0057
353 AGRANULOCYTOSIS 106 0.0057
354 MIXED LIVER INJURY 17 0.0056
355 LOCALISED OEDEMA 26 0.0056
356 SEPTIC SHOCK 242 0.0056
357 BACTERAEMIA 66 0.0056
358 DUODENAL ULCER 39 0.0055
359 ASCITES 161 0.0055
360 DERMATITIS EXFOLIATIVE GENERALISED 19 0.0055
361 OESOPHAGEAL ULCER 21 0.0055
362 C-REACTIVE PROTEIN INCREASED 198 0.0054
363 CYTOMEGALOVIRUS INFECTION REACTIVATION 24 0.0054
364 THROMBOTIC THROMBOCYTOPENIC PURPURA 19 0.0054
365 PAINFUL RESPIRATION 13 0.0054
366 LIVER FUNCTION TEST INCREASED 115 0.0054
367 HYPERURICAEMIA 22 0.0053
368 LARGE INTESTINAL HAEMORRHAGE 12 0.0053
369 DEATH 4577 0.0053
370 BLOOD ALKALINE PHOSPHATASE INCREASED 131 0.0053
371 OESOPHAGEAL STENOSIS 15 0.0053
372 IRITIS 16 0.0053
373 KERATITIS 16 0.0053
374 LYMPHOCYTE COUNT DECREASED 92 0.0052
375 GENERAL PHYSICAL HEALTH DETERIORATION 602 0.0052
376 PARAPLEGIA 15 0.0052
377 ERYSIPELAS 26 0.0052
378 EOSINOPHIL COUNT INCREASED 43 0.0052
379 LARGE INTESTINAL ULCER 14 0.0052
380 GOITRE 21 0.0051
381 DEHYDRATION 684 0.0051
382 EOSINOPHILIA 89 0.0051
383 EOSINOPHILIC PNEUMONIA 16 0.0051
384 METASTASES TO BONE 83 0.0051
385 NEOPLASM RECURRENCE 17 0.0050
386 APPETITE DISORDER 33 0.0050
387 SMALL INTESTINAL OBSTRUCTION 61 0.0050
388 ATRIOVENTRICULAR BLOCK 38 0.0049
389 NEUROLOGICAL SYMPTOM 28 0.0049
390 DIARRHOEA 3159 0.0049
391 GENERAL PHYSICAL CONDITION ABNORMAL 33 0.0049
392 STAPHYLOCOCCAL SEPSIS 24 0.0049
393 DECREASED APPETITE 1128 0.0049
394 PNEUMONIA ASPIRATION 120 0.0048
395 AUTONOMIC NERVOUS SYSTEM IMBALANCE 14 0.0048
396 GASTRIC PERFORATION 13 0.0048
397 ALTERED STATE OF CONSCIOUSNESS 103 0.0047
398 ORAL FUNGAL INFECTION 13 0.0047
399 KLEBSIELLA INFECTION 24 0.0047
400 BRAIN ABSCESS 12 0.0047
401 FAECAL CALPROTECTIN INCREASED 15 0.0047
402 NEPHROPATHY TOXIC 53 0.0047
403 MUCOSAL INFLAMMATION 123 0.0047
404 CYTOMEGALOVIRUS INFECTION 78 0.0047
405 ATYPICAL PNEUMONIA 14 0.0047
406 PERIPHERAL ISCHAEMIA 19 0.0046
407 STRESS CARDIOMYOPATHY 27 0.0046
408 PANCREATITIS 244 0.0046
409 ACUTE HEPATIC FAILURE 63 0.0046
410 LOWER GASTROINTESTINAL HAEMORRHAGE 34 0.0046
411 HYPOXIA 161 0.0046
412 RESPIRATORY FAILURE 333 0.0046
413 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 116 0.0045
414 ACUTE RESPIRATORY FAILURE 85 0.0044
415 CARDIOMYOPATHY 65 0.0044
416 GASTROENTERITIS 64 0.0044
417 SINUS TACHYCARDIA 62 0.0044
418 RASH PRURITIC 236 0.0044
419 BLOOD CREATINE PHOSPHOKINASE INCREASED 125 0.0043
420 UROSEPSIS 40 0.0043
421 CARDIAC DYSFUNCTION 16 0.0043
422 SHOCK HAEMORRHAGIC 35 0.0043
423 ABDOMINAL ABSCESS 19 0.0043
424 RENAL TUBULAR NECROSIS 42 0.0043
425 FEBRILE NEUTROPENIA 283 0.0043
426 NEOPLASM 49 0.0043
427 PULMONARY EMBOLISM 405 0.0043
428 DEAFNESS NEUROSENSORY 14 0.0043
429 HYPERPYREXIA 18 0.0042
430 RASH 1845 0.0042
431 MALNUTRITION 47 0.0042
432 ACIDOSIS 32 0.0042
433 SERUM FERRITIN INCREASED 22 0.0042
434 HYPOMAGNESAEMIA 58 0.0042
435 GAMMA-GLUTAMYLTRANSFERASE INCREASED 92 0.0041
436 HYPERBILIRUBINAEMIA 43 0.0041
437 HUMERUS FRACTURE 20 0.0041
438 DIABETES MELLITUS 316 0.0041
439 EXTRAVASATION 17 0.0041
440 CONJUNCTIVITIS 76 0.0041
441 HAEMOPTYSIS 114 0.0041
442 CHOLECYSTITIS ACUTE 23 0.0041
443 CARDIAC FAILURE ACUTE 27 0.0040
444 PRODUCT PREPARATION ERROR 83 0.0040
445 LUNG ADENOCARCINOMA 12 0.0040
446 PNEUMOTHORAX 63 0.0040
447 ELECTROLYTE IMBALANCE 46 0.0040
448 LYMPHADENOPATHY 140 0.0040
449 NEUTROPENIC SEPSIS 28 0.0039
450 KETOACIDOSIS 29 0.0039
451 BRONCHOPULMONARY ASPERGILLOSIS 30 0.0039
452 BLOOD DISORDER 31 0.0039
453 INFUSION RELATED REACTION 256 0.0039
454 HYPOCALCAEMIA 73 0.0039
455 CARDIOGENIC SHOCK 55 0.0038
456 ANAEMIA 727 0.0038
457 THROMBOCYTOPENIA 426 0.0038
458 PYELONEPHRITIS 33 0.0038
459 HYPOVOLAEMIA 22 0.0038
460 KIDNEY TRANSPLANT REJECTION 18 0.0037
461 HEPATIC ENCEPHALOPATHY 35 0.0037
462 PANCYTOPENIA 209 0.0037
463 PERITONITIS 77 0.0037
464 HEPATIC NECROSIS 14 0.0037
465 DIPLOPIA 96 0.0037
466 BRONCHIOLITIS 13 0.0037
467 VASCULITIS 43 0.0037
468 NEUTROPHIL COUNT DECREASED 150 0.0037
469 JAUNDICE CHOLESTATIC 13 0.0037
470 ARTHRITIS 289 0.0037
471 DEMYELINATION 15 0.0037
472 DIVERTICULUM INTESTINAL 16 0.0037
473 FIBRIN D DIMER INCREASED 13 0.0037
474 NEOPLASM PROGRESSION 126 0.0036
475 HYPERNATRAEMIA 18 0.0036
476 BONE LESION 13 0.0036
477 DERMATITIS BULLOUS 26 0.0036
478 PERICARDITIS 60 0.0036
479 SUPRAVENTRICULAR TACHYCARDIA 34 0.0035
480 VASCULAR DEVICE INFECTION 16 0.0035
481 ATRIAL FLUTTER 28 0.0035
482 ASPERGILLUS INFECTION 23 0.0035
483 ACUTE CORONARY SYNDROME 29 0.0035
484 BLOOD CREATININE INCREASED 228 0.0035
485 RETINAL DETACHMENT 32 0.0035
486 GENERALISED OEDEMA 43 0.0035
487 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 33 0.0035
488 LEFT VENTRICULAR DYSFUNCTION 23 0.0034
489 INCORRECT PRODUCT STORAGE 45 0.0034
490 IMMUNE SYSTEM DISORDER 45 0.0034
491 NECROSIS 19 0.0034
492 FACIAL PARESIS 12 0.0034
493 SKIN INFECTION 38 0.0034
494 PLEURISY 20 0.0034
495 COLECTOMY 19 0.0034
496 CARDIOTOXICITY 30 0.0034
497 ATRIAL FIBRILLATION 326 0.0033
498 WEIGHT FLUCTUATION 35 0.0033
499 HYPOVOLAEMIC SHOCK 16 0.0033
500 ENDOCARDITIS 17 0.0033
501 FLANK PAIN 31 0.0033
502 CLOSTRIDIUM DIFFICILE INFECTION 72 0.0033
503 HERPES VIRUS INFECTION 19 0.0033
504 HEPATIC ENZYME INCREASED 223 0.0033
505 INTRACRANIAL PRESSURE INCREASED 18 0.0032
506 DELIRIUM 112 0.0032
507 STAPHYLOCOCCAL BACTERAEMIA 14 0.0032
508 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 74 0.0032
509 LUNG DISORDER 155 0.0032
510 RENAL DISORDER 147 0.0032
511 TASTE DISORDER 64 0.0032
512 HYDROCEPHALUS 17 0.0031
513 BLOOD URIC ACID INCREASED 18 0.0031
514 ORAL CANDIDIASIS 41 0.0031
515 HAEMOLYSIS 24 0.0031
516 CARDIOPULMONARY FAILURE 12 0.0031
517 BLOOD SODIUM DECREASED 58 0.0031
518 PNEUMONIA 990 0.0031
519 TRANSFUSION 32 0.0031
520 BRAIN NEOPLASM 28 0.0030
521 RHABDOMYOLYSIS 127 0.0030
522 HEPATIC PAIN 13 0.0030
523 PANCREATIC DISORDER 15 0.0030
524 SHOCK 70 0.0030
525 PULMONARY TUBERCULOSIS 13 0.0030
526 NEOPLASM MALIGNANT 203 0.0030
527 ATAXIA 36 0.0030
528 MUSCULAR WEAKNESS 344 0.0030
529 LIVER FUNCTION TEST ABNORMAL 88 0.0030
530 CORONAVIRUS INFECTION 20 0.0030
531 STOMATITIS 182 0.0030
532 APPENDICITIS 28 0.0030
533 CEREBRAL HAEMORRHAGE 107 0.0030
534 CEREBRAL INFARCTION 73 0.0030
535 OFF LABEL USE 2616 0.0030
536 CHROMATURIA 67 0.0030
537 MELANOCYTIC NAEVUS 13 0.0030
538 CARDIAC FAILURE 238 0.0030
539 ACUTE RESPIRATORY DISTRESS SYNDROME 52 0.0029
540 HYPERKALAEMIA 103 0.0029
541 JAUNDICE 79 0.0029
542 SKIN REACTION 41 0.0029
543 DIVERTICULITIS 80 0.0029
544 PRODUCT STORAGE ERROR 249 0.0028
545 ASPIRATION 31 0.0028
546 LUNG INFILTRATION 25 0.0028
547 ABDOMINAL TENDERNESS 14 0.0028
548 HYDRONEPHROSIS 21 0.0028
549 HICCUPS 23 0.0028
550 NEUROTOXICITY 49 0.0028
551 HYPOPHAGIA 71 0.0028
552 CIRCULATORY COLLAPSE 47 0.0028
553 NEUROPATHY PERIPHERAL 262 0.0028
554 LYMPHOEDEMA 19 0.0027
555 HEPATOMEGALY 27 0.0027
556 HAEMORRHAGE INTRACRANIAL 41 0.0027
557 FEMORAL NECK FRACTURE 14 0.0027
558 CEREBRAL ISCHAEMIA 14 0.0027
559 RENAL IMPAIRMENT 226 0.0027
560 PULMONARY MASS 40 0.0027
561 UPPER GASTROINTESTINAL HAEMORRHAGE 45 0.0027
562 CHILLS 313 0.0027
563 RENAL CELL CARCINOMA 13 0.0027
564 BLOOD TESTOSTERONE DECREASED 18 0.0026
565 ANAL FISTULA 14 0.0026
566 BUNDLE BRANCH BLOCK RIGHT 12 0.0026
567 PHOTOSENSITIVITY REACTION 43 0.0026
568 DERMATITIS EXFOLIATIVE 13 0.0026
569 LEUKOCYTOSIS 47 0.0026
570 HAEMATURIA 88 0.0026
571 CEREBRAL DISORDER 19 0.0026
572 NEUTROPENIA 349 0.0026
573 WOUND INFECTION 28 0.0026
574 RENAL FAILURE 337 0.0025
575 HYPERKERATOSIS 14 0.0025
576 PROTEINURIA 48 0.0025
577 ACUTE MYOCARDIAL INFARCTION 74 0.0025
578 THERAPY PARTIAL RESPONDER 39 0.0025
579 MELAENA 55 0.0025
580 HYPOTENSION 494 0.0025
581 HERPES SIMPLEX 16 0.0025
582 CYTOPENIA 30 0.0024
583 PARALYSIS 35 0.0024
584 PRURITUS 936 0.0024
585 OEDEMA 132 0.0024
586 VENTRICULAR TACHYCARDIA 40 0.0024
587 INFLAMMATORY MARKER INCREASED 12 0.0024
588 WEIGHT DECREASED 674 0.0024
589 PAPULE 17 0.0024
590 MENTAL STATUS CHANGES 67 0.0024
591 ANAL ABSCESS 13 0.0024
592 HAIR COLOUR CHANGES 30 0.0024
593 HEPATIC ENZYME ABNORMAL 12 0.0024
594 DEVICE RELATED INFECTION 37 0.0024
595 RESPIRATORY DISTRESS 66 0.0024
596 EPILEPSY 73 0.0024
597 COLITIS ISCHAEMIC 16 0.0024
598 COVID-19 PNEUMONIA 28 0.0024
599 POSTOPERATIVE WOUND INFECTION 16 0.0024
600 GRAFT VERSUS HOST DISEASE 17 0.0024
601 CELLULITIS 119 0.0024
602 STREPTOCOCCAL INFECTION 13 0.0023
603 HOSPICE CARE 23 0.0023
604 MACULAR OEDEMA 13 0.0023
605 ESCHERICHIA INFECTION 19 0.0023
606 HEMIPLEGIA 19 0.0023
607 INTESTINAL OBSTRUCTION 85 0.0023
608 VOMITING 1060 0.0023
609 PLATELET COUNT DECREASED 240 0.0022
610 ABDOMINAL PAIN 519 0.0022
611 HYPERTHERMIA 17 0.0022
612 DECUBITUS ULCER 18 0.0022
613 FATIGUE 1715 0.0022
614 RASH PAPULAR 49 0.0022
615 HEMIPARESIS 37 0.0022
616 CENTRAL NERVOUS SYSTEM LESION 30 0.0022
617 PHARYNGITIS 27 0.0022
618 JOINT EFFUSION 15 0.0022
619 PULMONARY HAEMORRHAGE 17 0.0022
620 COLITIS ULCERATIVE 97 0.0022
621 GROIN PAIN 19 0.0022
622 MOTOR DYSFUNCTION 22 0.0022
623 DERMATITIS ALLERGIC 27 0.0021
624 CONSTIPATION 467 0.0021
625 ANGIOPATHY 12 0.0021
626 PANCREATITIS ACUTE 48 0.0021
627 SPLENOMEGALY 25 0.0021
628 LIVER INJURY 52 0.0021
629 DYSPHAGIA 199 0.0021
630 ANURIA 18 0.0021
631 EPSTEIN-BARR VIRUS INFECTION 13 0.0021
632 EJECTION FRACTION DECREASED 32 0.0021
633 GASTRIC ULCER 39 0.0020
634 INFLAMMATION 105 0.0020
635 LEUKOPENIA 101 0.0020
636 GASTROINTESTINAL INFECTION 18 0.0020
637 HAEMORRHOIDS 39 0.0020
638 GASTROINTESTINAL DISORDER 179 0.0020
639 NODULE 26 0.0020
640 NIGHT SWEATS 64 0.0020
641 PSEUDOMONAS INFECTION 17 0.0020
642 ASTHENIA 745 0.0020
643 DISEASE PROGRESSION 233 0.0020
644 SKIN MASS 13 0.0019
645 DEEP VEIN THROMBOSIS 126 0.0019
646 SYNCOPE 193 0.0019
647 FAECES SOFT 14 0.0019
648 NERVOUS SYSTEM DISORDER 60 0.0019
649 APHASIA 58 0.0019
650 SQUAMOUS CELL CARCINOMA 18 0.0019
651 DRY MOUTH 155 0.0019
652 THIRST 34 0.0019
653 SKIN LESION 52 0.0019
654 CANDIDA INFECTION 32 0.0019
655 EATING DISORDER 40 0.0019
656 DEPRESSED LEVEL OF CONSCIOUSNESS 74 0.0019
657 CARDIAC ARREST 153 0.0019
658 CARDIO-RESPIRATORY ARREST 77 0.0018
659 LYMPHOPENIA 26 0.0018
660 FACE OEDEMA 31 0.0018
661 GASTROINTESTINAL HAEMORRHAGE 152 0.0018
662 RECTAL HAEMORRHAGE 78 0.0018
663 SPINAL COMPRESSION FRACTURE 15 0.0018
664 DYSPNOEA 1026 0.0018
665 DEAFNESS 47 0.0018
666 MASS 25 0.0018
667 PULMONARY OEDEMA 80 0.0018
668 PRODUCT USE IN UNAPPROVED INDICATION 441 0.0018
669 DYSPNOEA EXERTIONAL 67 0.0018
670 RASH GENERALISED 46 0.0018
671 NAUSEA 1401 0.0018
672 REBOUND EFFECT 20 0.0018
673 BODY TEMPERATURE INCREASED 36 0.0018
674 OEDEMA PERIPHERAL 215 0.0018
675 CONFUSIONAL STATE 283 0.0017
676 URINARY RETENTION 58 0.0017
677 IRON DEFICIENCY ANAEMIA 16 0.0017
678 RASH MACULAR 60 0.0017
679 BACTERIAL INFECTION 32 0.0017
680 NEPHROPATHY 16 0.0017
681 BACK PAIN 396 0.0017
682 HAEMATOCHEZIA 94 0.0017
683 URINARY TRACT INFECTION 290 0.0017
684 HYPOGLYCAEMIA 82 0.0017
685 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 88 0.0017
686 HAEMATOTOXICITY 16 0.0017
687 MUSCULOSKELETAL CHEST PAIN 26 0.0017
688 SUBDURAL HAEMATOMA 24 0.0017
689 MYALGIA 285 0.0017
690 GASTROINTESTINAL INFLAMMATION 13 0.0017
691 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 91 0.0017
692 GASTRIC HAEMORRHAGE 19 0.0016
693 RENAL FAILURE ACUTE 70 0.0016
694 COGNITIVE DISORDER 77 0.0016
695 BLOOD ALBUMIN DECREASED 13 0.0016
696 BLOOD TEST ABNORMAL 23 0.0016
697 ANAPHYLACTIC REACTION 90 0.0016
698 VITREOUS FLOATERS 16 0.0016
699 SEIZURE 188 0.0016
700 THERAPY NON-RESPONDER 73 0.0016
701 BONE MARROW FAILURE 33 0.0016
702 COAGULOPATHY 27 0.0016
703 MALAISE 704 0.0016
704 DRUG RESISTANCE 41 0.0016
705 SPINAL OSTEOARTHRITIS 14 0.0016
706 INFECTION 230 0.0016
707 POLYURIA 13 0.0016
708 ABNORMAL FAECES 13 0.0016
709 SUBARACHNOID HAEMORRHAGE 16 0.0016
710 SINUS BRADYCARDIA 15 0.0016
711 HOSPITALISATION 237 0.0015
712 INFLAMMATORY BOWEL DISEASE 15 0.0015
713 INCREASED APPETITE 29 0.0015
714 TACHYCARDIA 134 0.0015
715 MULTI-ORGAN FAILURE 26 0.0015
716 HYPOTONIA 15 0.0015
717 DYSURIA 55 0.0015
718 TYPE 2 DIABETES MELLITUS 50 0.0015
719 FEEDING DISORDER 30 0.0015
720 METABOLIC ACIDOSIS 47 0.0015
721 EYE INFLAMMATION 14 0.0015
722 HERPES ZOSTER 84 0.0015
723 VERTIGO 89 0.0015
724 COUGH 408 0.0015
725 INFLUENZA LIKE ILLNESS 119 0.0014
726 HYPERTENSIVE CRISIS 16 0.0014
727 ANAPHYLACTIC SHOCK 37 0.0014
728 STATUS EPILEPTICUS 16 0.0014
729 BREAST PAIN 15 0.0014
730 NEURALGIA 34 0.0014
731 SPINAL FRACTURE 28 0.0014
732 STAPHYLOCOCCAL INFECTION 46 0.0014
733 ARRHYTHMIA 66 0.0014
734 ARTHRALGIA 576 0.0014
735 PRODUCTIVE COUGH 66 0.0014
736 CYSTITIS 44 0.0014
737 NEUTROPHIL COUNT INCREASED 14 0.0014
738 SPINAL PAIN 16 0.0014
739 ISCHAEMIC STROKE 24 0.0013
740 RESPIRATORY TRACT INFECTION 35 0.0013
741 ORAL PAIN 30 0.0013
742 ANAL INCONTINENCE 12 0.0013
743 THROMBOTIC MICROANGIOPATHY 13 0.0013
744 ORTHOSTATIC HYPOTENSION 23 0.0013
745 PRESYNCOPE 32 0.0013
746 HEADACHE 813 0.0013
747 HYPOTHERMIA 13 0.0013
748 MUSCULOSKELETAL PAIN 67 0.0013
749 RASH ERYTHEMATOUS 61 0.0013
750 RHEUMATOID ARTHRITIS 144 0.0013
751 MUSCLE ATROPHY 16 0.0013
752 HAEMATEMESIS 32 0.0013
753 VENTRICULAR FIBRILLATION 14 0.0013
754 BLOOD PRESSURE DECREASED 83 0.0012
755 MYELODYSPLASTIC SYNDROME 18 0.0012
756 RESPIRATORY DISORDER 37 0.0012
757 BLINDNESS 50 0.0012
758 NECK PAIN 68 0.0012
759 DISORIENTATION 48 0.0012
760 GENERALISED TONIC-CLONIC SEIZURE 20 0.0012
761 DYSARTHRIA 45 0.0012
762 OXYGEN SATURATION DECREASED 67 0.0012
763 PRODUCT ADMINISTRATION ERROR 24 0.0012
764 HYPERTENSION 250 0.0012
765 BLOOD IRON DECREASED 14 0.0012
766 MYOCLONUS 14 0.0012
767 WHITE BLOOD CELL COUNT INCREASED 45 0.0012
768 MYELOSUPPRESSION 42 0.0012
769 BONE PAIN 68 0.0012
770 ANGINA PECTORIS 33 0.0012
771 DRY EYE 57 0.0011
772 INCONTINENCE 12 0.0011
773 COVID-19 199 0.0011
774 TOXICITY TO VARIOUS AGENTS 190 0.0011
775 RETCHING 24 0.0011
776 AGEUSIA 28 0.0011
777 SKIN ULCER 29 0.0011
778 HAEMOGLOBIN DECREASED 115 0.0011
779 PEMPHIGUS 14 0.0011
780 MOVEMENT DISORDER 35 0.0011
781 INTERNATIONAL NORMALISED RATIO INCREASED 31 0.0011
782 VISUAL ACUITY REDUCED 36 0.0011
783 LACTIC ACIDOSIS 35 0.0011
784 LOWER RESPIRATORY TRACT INFECTION 49 0.0011
785 GAIT INABILITY 36 0.0011
786 ULCER 17 0.0011
787 ABDOMINAL PAIN LOWER 27 0.0011
788 ABSCESS 17 0.0011
789 EYE DISORDER 35 0.0011
790 CHEST PAIN 197 0.0011
791 ABDOMINAL DISTENSION 111 0.0011
792 ERYTHEMA 218 0.0011
793 UPPER RESPIRATORY TRACT INFECTION 49 0.0011
794 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 31 0.0011
795 VISION BLURRED 145 0.0011
796 ECZEMA 55 0.0010
797 BLISTER 59 0.0010
798 POST PROCEDURAL COMPLICATION 20 0.0010
799 SECRETION DISCHARGE 13 0.0010
800 IMPAIRED GASTRIC EMPTYING 14 0.0010
801 LETHARGY 59 0.0010
802 ABDOMINAL PAIN UPPER 210 0.0010
803 DIABETES MELLITUS INADEQUATE CONTROL 18 0.0010
804 WHITE BLOOD CELL COUNT DECREASED 110 0.0010
805 HYPERSOMNIA 29 0.0010
806 HEPATIC CIRRHOSIS 19 0.0010
807 HAEMATOCRIT DECREASED 20 0.0010
808 BLINDNESS UNILATERAL 14 0.0010
809 TOOTH DISORDER 22 0.0010
810 THROMBOSIS 79 0.0010
811 ADVERSE REACTION 13 0.0010
812 VISUAL IMPAIRMENT 121 0.0010
813 HEPATIC STEATOSIS 18 0.0010
814 COLD SWEAT 17 0.0010
815 FREQUENT BOWEL MOVEMENTS 26 0.0010
816 RESTLESSNESS 35 0.0010
817 CYANOSIS 15 0.0010
818 MOUTH ULCERATION 20 0.0009
819 CARDIOVASCULAR DISORDER 24 0.0009
820 CHOLELITHIASIS 31 0.0009
821 OSTEOMYELITIS 17 0.0009
822 FEELING COLD 26 0.0009
823 BLOOD POTASSIUM DECREASED 28 0.0009
824 DEMENTIA 26 0.0009
825 HAEMATOMA 24 0.0009
826 EAR PAIN 18 0.0009
827 BLOOD POTASSIUM INCREASED 15 0.0009
828 DYSPHONIA 54 0.0009
829 HYPOAESTHESIA 137 0.0009
830 PULMONARY HYPERTENSION 19 0.0009
831 MANIA 15 0.0009
832 BRONCHOSPASM 13 0.0009
833 SLEEP DISORDER 64 0.0009
834 SOMNOLENCE 182 0.0009
835 BASAL CELL CARCINOMA 14 0.0009
836 BLOOD UREA INCREASED 15 0.0009
837 PULMONARY FIBROSIS 17 0.0009
838 URINARY INCONTINENCE 26 0.0009
839 PARAESTHESIA 138 0.0009
840 VIRAL INFECTION 29 0.0009
841 ORAL HERPES 17 0.0009
842 PHOTOPHOBIA 16 0.0008
843 DRUG INTOLERANCE 82 0.0008
844 FRACTURE 16 0.0008
845 OROPHARYNGEAL PAIN 78 0.0008
846 COMA 40 0.0008
847 ACUTE MYELOID LEUKAEMIA 13 0.0008
848 PRURITUS GENERALISED 18 0.0008
849 SKIN DISCOLOURATION 38 0.0008
850 BRONCHITIS 61 0.0008
851 DRY SKIN 110 0.0008
852 KIDNEY INFECTION 16 0.0008
853 FALL 270 0.0008
854 HYPERSENSITIVITY 150 0.0008
855 INSOMNIA 212 0.0008
856 GAIT DISTURBANCE 152 0.0008
857 CORONARY ARTERY DISEASE 24 0.0008
858 HEAD DISCOMFORT 14 0.0008
859 HYPOACUSIS 34 0.0008
860 SPEECH DISORDER 41 0.0008
861 DYSGEUSIA 58 0.0008
862 LOSS OF CONSCIOUSNESS 100 0.0008
863 OCULAR HYPERAEMIA 37 0.0008
864 ADVERSE DRUG REACTION 70 0.0008
865 ELECTROCARDIOGRAM QT PROLONGED 28 0.0008
866 EPISTAXIS 58 0.0008
867 CEREBROVASCULAR ACCIDENT 131 0.0008
868 RED BLOOD CELL COUNT DECREASED 22 0.0008
869 POLLAKIURIA 32 0.0008
870 URTICARIA 128 0.0008
871 EYE PAIN 43 0.0008
872 BLOOD GLUCOSE ABNORMAL 14 0.0008
873 PAIN IN EXTREMITY 223 0.0008
874 CONDITION AGGRAVATED 229 0.0008
875 SKIN EXFOLIATION 63 0.0007
876 LABORATORY TEST ABNORMAL 22 0.0007
877 RIB FRACTURE 15 0.0007
878 MYOCARDIAL INFARCTION 127 0.0007
879 HYPERHIDROSIS 93 0.0007
880 DYSPEPSIA 71 0.0007
881 PERIPHERAL SWELLING 110 0.0007
882 FEMUR FRACTURE 22 0.0007
883 PAIN 433 0.0007
884 PALLOR 19 0.0007
885 OSTEONECROSIS OF JAW 17 0.0007
886 CONTUSION 66 0.0007
887 HIP FRACTURE 22 0.0007
888 DIZZINESS 341 0.0007
889 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 23 0.0007
890 MUSCULOSKELETAL STIFFNESS 59 0.0007
891 HAEMORRHAGE 70 0.0007
892 GOUT 12 0.0007
893 BLOOD PRESSURE SYSTOLIC INCREASED 13 0.0007
894 INFLUENZA 74 0.0007
895 CARDIAC DISORDER 62 0.0007
896 CHRONIC KIDNEY DISEASE 50 0.0007
897 SINUSITIS 67 0.0007
898 TINNITUS 30 0.0007
899 TRANSIENT ISCHAEMIC ATTACK 22 0.0007
900 WEIGHT INCREASED 146 0.0007
901 THERAPY CESSATION 33 0.0006
902 HOT FLUSH 48 0.0006
903 AMNESIA 41 0.0006
904 SWELLING FACE 40 0.0006
905 JOINT STIFFNESS 16 0.0006
906 BRADYCARDIA 32 0.0006
907 DEPRESSION 136 0.0006
908 CARDIAC FAILURE CONGESTIVE 48 0.0006
909 PSORIASIS 78 0.0006
910 FULL BLOOD COUNT DECREASED 12 0.0006
911 PSORIATIC ARTHROPATHY 24 0.0006
912 TREATMENT NONCOMPLIANCE 32 0.0006
913 DYSSTASIA 17 0.0006
914 LIMB DISCOMFORT 18 0.0006
915 TREMOR 96 0.0006
916 LIP SWELLING 19 0.0006
917 FUNGAL INFECTION 19 0.0006
918 PRODUCT USE ISSUE 107 0.0006
919 SWELLING 53 0.0006
920 ALOPECIA 110 0.0006
921 CONVULSION 32 0.0006
922 CATARACT 33 0.0006
923 FAECES DISCOLOURED 12 0.0006
924 MUSCLE SPASMS 101 0.0005
925 JOINT SWELLING 66 0.0005
926 PSYCHOTIC DISORDER 16 0.0005
927 IRRITABILITY 32 0.0005
928 FLATULENCE 30 0.0005
929 CHEST DISCOMFORT 54 0.0005
930 MEMORY IMPAIRMENT 72 0.0005
931 GASTROOESOPHAGEAL REFLUX DISEASE 42 0.0005
932 DRUG INEFFECTIVE 682 0.0005
933 ABDOMINAL DISCOMFORT 86 0.0005
934 EYE SWELLING 19 0.0005
935 ARTHROPATHY 28 0.0005
936 WOUND 14 0.0005
937 LACRIMATION INCREASED 15 0.0005
938 OSTEOARTHRITIS 21 0.0005
939 RHINORRHOEA 32 0.0005
940 FEELING HOT 30 0.0005
941 BALANCE DISORDER 42 0.0005
942 HEART RATE INCREASED 48 0.0005
943 DISEASE RECURRENCE 23 0.0005
944 ILLNESS 49 0.0005
945 DISCOMFORT 29 0.0005
946 RESPIRATORY ARREST 13 0.0005
947 ANXIETY 133 0.0005
948 GASTRIC DISORDER 16 0.0005
949 IMPAIRED HEALING 15 0.0005
950 NASOPHARYNGITIS 84 0.0005
951 BLOOD PRESSURE INCREASED 69 0.0005
952 DEPRESSED MOOD 23 0.0004
953 FLUID RETENTION 22 0.0004
954 ILL-DEFINED DISORDER 26 0.0004
955 DRUG ADMINISTRATION ERROR 13 0.0004
956 WHEEZING 25 0.0004
957 EYE PRURITUS 14 0.0004
958 DRUG INTERACTION 65 0.0004
959 FLUSHING 41 0.0004
960 PALPITATIONS 47 0.0004
961 HEART RATE DECREASED 14 0.0004
962 HALLUCINATION 30 0.0004
963 NO ADVERSE EVENT 72 0.0004
964 ACNE 30 0.0004
965 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 28 0.0004
966 MENTAL DISORDER 17 0.0004
967 TREATMENT FAILURE 32 0.0004
968 ANGIOEDEMA 17 0.0004
969 THERAPEUTIC RESPONSE DECREASED 23 0.0004
970 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 18 0.0004
971 MOBILITY DECREASED 25 0.0003
972 SURGERY 20 0.0003
973 DISTURBANCE IN ATTENTION 18 0.0003
974 BLOOD GLUCOSE INCREASED 60 0.0003
975 ABNORMAL BEHAVIOUR 12 0.0003
976 LUNG NEOPLASM MALIGNANT 12 0.0003
977 PRODUCT DOSE OMISSION ISSUE 85 0.0003
978 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 52 0.0003
979 NEPHROLITHIASIS 13 0.0003
980 MIGRAINE 27 0.0003
981 NASAL CONGESTION 16 0.0003
982 BURNING SENSATION 19 0.0003
983 EYE IRRITATION 13 0.0002
984 ASTHMA 24 0.0002
985 AGITATION 15 0.0002
986 MATERNAL EXPOSURE DURING PREGNANCY 18 0.0002
987 FOETAL EXPOSURE DURING PREGNANCY 15 0.0002
988 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 13 0.0002
989 FEELING ABNORMAL 43 0.0002
990 OVERDOSE 31 0.0001
991 DRUG DOSE OMISSION 20 0.0001
992 INCORRECT DOSE ADMINISTERED 24 0.0001